Participant flow

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC · Source last updated 2025-12-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Nivolumab + Ipilimumab + Chemotherapy

   id

   FG000

   title

   Treatment A

2. description

   Chemotherapy only

   id

   FG001

   title

   Treatment B

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Adverse Event unrelated to study drug

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         3

      type

      participant withdrew consent

   3. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         4

      type

      no longer meets study criteria

   4. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         2

      type

      other reasons

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         361

      2. group Id

         FG001

         num Subjects

         358

      comment

      = Participants Randomized

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         358

      2. group Id

         FG001

         num Subjects

         349

      comment

      = Participants treated

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         9

      type

      NOT COMPLETED

   title

   Randomization

2. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         184

      2. group Id

         FG001

         num Subjects

         174

      type

      Disease Progression

   2. reasons

      1. group Id

         FG000

         num Subjects

         70

      2. group Id

         FG001

         num Subjects

         24

      type

      Study Drug Toxicity

   3. reasons

      1. group Id

         FG000

         num Subjects

         7

      2. group Id

         FG001

         num Subjects

         1

      type

      Death

   4. reasons

      1. group Id

         FG000

         num Subjects

         31

      2. group Id

         FG001

         num Subjects

         27

      type

      Adverse event unrelated to study drug

   5. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         10

      type

      Request to D/C treatment

   6. reasons

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         5

      type

      Participant withdrew consent

   7. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         1

      type

      Lost to Follow-up

   8. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         2

      type

      Administrative reason by sponsor

   9. reasons

      1. group Id

         FG000

         num Subjects

         10

      2. group Id

         FG001

         num Subjects

         5

      type

      other reasons

   10. reasons

       1. group Id

          FG000

          num Subjects

          1

       2. group Id

          FG001

          num Subjects

          0

       type

       Not reported

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         358

      2. group Id

         FG001

         num Subjects

         349

      comment

      = Participants treated

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         49

      2. group Id

         FG001

         num Subjects

         100

      comment

      = completing treatment

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         309

      2. group Id

         FG001

         num Subjects

         249

      type

      NOT COMPLETED

   title

   Treatment Period

pre Assignment Details

707 Randomized and treated

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice